Table 1 Summary of basic clinical and FAP IHC information of the cohort of 15 malignant gliomas
Sample Number | Pathology | Primary vsersu recurrent | IDH1 Status | Perivascular FAP | Parenchymal FAP |
|---|---|---|---|---|---|
MGG7 | GBM | Primary | Wild type | – | ++ |
MGG8 | GBM | Primary | Wild type | – | ++ |
MGG63 | GBM | Recurrent | Wild type | – | + |
MGG65 | GBM | Primary | Wild type | – | ++ |
MGG66 | GBM | Primary | Wild type | – | + |
MGG67 | GBM | Primary | Wild type | – | + |
MGG81 | GBM | Primary | Mutant | – | + |
MGG90 | GBM | Primary | Wild type | – | ++ |
MGG100 | GBM | Primary | Wild type | – | + |
MGG125 | GBM | Primary | Wild type | + | + |
MGG153 | GBM | Primary | Wild type | + | + |
MGG162 | AA | Primary | Mutant | – | + |
MGG168 | GBM | Recurrent | Wild type | + | – |
MGG169 | GBM | Primary | Wild type | – | + |
MGG225 | GBM | Primary | Wild type | + | + |